Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population

PHASE3RecruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

February 27, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Chronic InflammationMobilityMuscle PainJoint Pain

Interventions

DRUG

Maolactin

Once daily dose of 2 capsules containing a total of 500mg/day Maolactin

DRUG

Maltodextrin

Once daily dose of 2 capsules of Maltodextrin containing a total of 0mg/day Maolactin

Trial Locations (1)

RECRUITING

RDC Clinical Pty Ltd, Brisbane

All Listed Sponsors

lead

RDC Clinical Pty Ltd

INDUSTRY